Article Information
History
- September 22, 2021.
Article Versions
- Version 1 (September 20, 2021 - 16:19).
- Version 2 (September 21, 2021 - 23:13).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Merav Mofaz, MSc1,
- Matan Yechezkel, MSc1,
- Grace Guan2,
- Margaret L. Brandeau, PhD2,
- Tal Patalon, MD3,
- Sivan Gazit, MD3,
- Dan Yamin, PhD1,4,+ and
- Erez Shmueli, PhD1,5,+,*
- 1Department of Industrial Engineering, Tel Aviv University, Tel Aviv, Israel
- 2Department of Management Science and Engineering, Stanford University, Stanford CA, USA
- 3Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel
- 4Center for Combatting Pandemics, Tel Aviv University, Tel Aviv, Israel
- 5MIT Media Lab, Cambridge MA, USA
- ↵*Corresponding author. Email: shmueli{at}tau.ac.il
↵+ Equal contribution
Posted September 22, 2021.
Self-reported and physiological reactions to the third BNT162b2 mRNA COVID-19 (booster) vaccine dose
